- Home
- SND vs PLRX Comparison
SND vs PLRX Comparison
Compare SND & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SND
- PLRX
- Stock Information
- Founded
- SND 2011
- PLRX 2015
- Country
- SND United States
- PLRX United States
- Employees
- SND N/A
- PLRX N/A
- Industry
- SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- SND Industrials
- PLRX Health Care
- Exchange
- SND Nasdaq
- PLRX Nasdaq
- Market Cap
- SND 78.9M
- PLRX 84.7M
- IPO Year
- SND 2016
- PLRX 2020
- Fundamental
- Price
- SND $2.13
- PLRX $1.28
- Analyst Decision
- SND Hold
- PLRX Hold
- Analyst Count
- SND 1
- PLRX 10
- Target Price
- SND $2.25
- PLRX $9.79
- AVG Volume (30 Days)
- SND 111.3K
- PLRX 950.8K
- Earning Date
- SND 08-12-2025
- PLRX 08-06-2025
- Dividend Yield
- SND 4.70%
- PLRX N/A
- EPS Growth
- SND N/A
- PLRX N/A
- EPS
- SND N/A
- PLRX N/A
- Revenue
- SND $293,878,000.00
- PLRX N/A
- Revenue This Year
- SND N/A
- PLRX N/A
- Revenue Next Year
- SND N/A
- PLRX N/A
- P/E Ratio
- SND N/A
- PLRX N/A
- Revenue Growth
- SND N/A
- PLRX N/A
- 52 Week Low
- SND $1.73
- PLRX $1.10
- 52 Week High
- SND $2.80
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- SND 63.58
- PLRX 36.66
- Support Level
- SND $2.06
- PLRX $1.56
- Resistance Level
- SND $2.24
- PLRX $1.70
- Average True Range (ATR)
- SND 0.08
- PLRX 0.12
- MACD
- SND 0.03
- PLRX -0.02
- Stochastic Oscillator
- SND 83.12
- PLRX 5.68
About SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.